Decision-analysis of transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt for portal hypertension

Hepatology

Volumn 29, Issue 5, 1999, Pages 1399-1405

  Brown Jr , Robert S ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; ECHOGRAPHY; HUMAN; OUTCOMES RESEARCH; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; SPLENORENAL SHUNT; SURVIVAL; TREATMENT OUTCOME;

EID: 0032947314     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290512     Document Type: Article

References (4)

1. Graves EJ. Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1989. National Center for Health Statistics. Vital Health Stat 13(108), 1991.
2. Colapinto RF, Stronell RD, Gildiner M, Ritchie AC, Langer B, Taylor BR, Blendis LM. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. Am J Roentgenol 1983;140:709-714.
3. Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the national digestive diseases advisory board. HEPATOLOGY 1995;221:1591-1597.
4. Sanyal AJ, Freedman AM, Luketic VA, Purdum III PP, Shiffman ML, DeMeo, Cole PE, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112:889-898.